BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22504665)

  • 1. microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6.
    van Baal JW; Verbeek RE; Bus P; Fassan M; Souza RF; Rugge M; ten Kate FJ; Vleggaar FP; Siersema PD
    Gut; 2013 May; 62(5):664-75. PubMed ID: 22504665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMP4 Signaling Is Able to Induce an Epithelial-Mesenchymal Transition-Like Phenotype in Barrett's Esophagus and Esophageal Adenocarcinoma through Induction of SNAIL2.
    Kestens C; Siersema PD; Offerhaus GJ; van Baal JW
    PLoS One; 2016; 11(5):e0155754. PubMed ID: 27191723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma.
    Wijnhoven BP; Hussey DJ; Watson DI; Tsykin A; Smith CM; Michael MZ;
    Br J Surg; 2010 Jun; 97(6):853-61. PubMed ID: 20301167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma.
    Pavlov K; Honing J; Meijer C; Boersma-van Ek W; Peters FT; van den Berg A; Karrenbeld A; Plukker JT; Kruyt FA; Kleibeuker JH
    Dig Liver Dis; 2015 Jan; 47(1):73-80. PubMed ID: 25445407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of miRNA-143, -145, -192, and -194 in esophageal epithelial cells upon acidic bile salt stimulation.
    Bus P; Siersema PD; Verbeek RE; van Baal JW
    Dis Esophagus; 2014 Aug; 27(6):591-600. PubMed ID: 24006894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP4 promotes a phenotype change of an esophageal squamous epithelium via up-regulation of KLF4.
    Yan W; Zhang H; Li J; Shen C; Xia Y; Wang P; Zhang Y; Feng J; Shao S; Yu X; Fang D
    Exp Mol Pathol; 2016 Oct; 101(2):259-266. PubMed ID: 27693253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
    Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma.
    Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H
    Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrative genomic approach in oesophageal cells identifies TRB3 as a bile acid responsive gene, downregulated in Barrett's oesophagus, which regulates NF-kappaB activation and cytokine levels.
    Duggan SP; Behan FM; Kirca M; Smith S; Reynolds JV; Long A; Kelleher D
    Carcinogenesis; 2010 May; 31(5):936-45. PubMed ID: 20139130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study.
    Revilla-Nuin B; Parrilla P; Lozano JJ; de Haro LF; Ortiz A; Martínez C; Munitiz V; de Angulo DR; Bermejo J; Molina J; Cayuela ML; Yélamos J
    Ann Surg; 2013 May; 257(5):886-93. PubMed ID: 23059500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dickkopf homologs in squamous mucosa of esophagitis patients are overexpressed compared with Barrett's patients and healthy controls.
    Ali I; Rafiee P; Hogan WJ; Jacob HJ; Komorowski RA; Haasler GB; Shaker R
    Am J Gastroenterol; 2006 Jul; 101(7):1437-48. PubMed ID: 16863544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer.
    Garman KS; Owzar K; Hauser ER; Westfall K; Anderson BR; Souza RF; Diehl AM; Provenzale D; Shaheen NJ
    Dig Dis Sci; 2013 Nov; 58(11):3178-88. PubMed ID: 23925817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours.
    Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
    Eur J Surg Oncol; 2007 Dec; 33(10):1164-8. PubMed ID: 17467227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of kinome profiles of Barrett's esophagus with normal squamous esophagus and normal gastric cardia.
    van Baal JW; Diks SH; Wanders RJ; Rygiel AM; Milano F; Joore J; Bergman JJ; Peppelenbosch MP; Krishnadath KK
    Cancer Res; 2006 Dec; 66(24):11605-12. PubMed ID: 17178854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evaluation of ablative therapy of Barrett's oesophagus.
    Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
    J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid and bile salt up-regulate BMP4 expression in human esophageal epithelium cells.
    Zhou G; Sun YG; Wang HB; Wang WQ; Wang XW; Fang DC
    Scand J Gastroenterol; 2009; 44(8):926-32. PubMed ID: 19488929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
    Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action.
    Tselepis C; Perry I; Dawson C; Hardy R; Darnton SJ; McConkey C; Stuart RC; Wright N; Harrison R; Jankowski JA
    Oncogene; 2002 Sep; 21(39):6071-81. PubMed ID: 12203119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
    Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
    BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
    Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.